BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10960514)

  • 1. Acute intravascular hemolysis secondaryto out-of-group platelet transfusion.
    Larsson LG; Welsh VJ; Ladd DJ
    Transfusion; 2000 Aug; 40(8):902-6. PubMed ID: 10960514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Intravascular Hemolysis Following an ABO Non-Identical Platelet Transfusion: A Case Report and Literature Review.
    Moinuddin IA; Millward P; Fletcher CH
    Am J Case Rep; 2019 Jul; 20():1075-1079. PubMed ID: 31332158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets.
    Mair B; Benson K
    Transfusion; 1998 Jan; 38(1):51-5. PubMed ID: 9482394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution.
    Balbuena-Merle R; West FB; Tormey CA; Hendrickson JE
    Transfusion; 2019 Jun; 59(6):1911-1915. PubMed ID: 30865314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions.
    Daniel-Johnson J; Leitman S; Klein H; Alter H; Lee-Stroka A; Scheinberg P; Pantin J; Quillen K
    Transfusion; 2009 Sep; 49(9):1845-9. PubMed ID: 19453987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy.
    Josephson CD; Mullis NC; Van Demark C; Hillyer CD
    Transfusion; 2004 Jun; 44(6):805-8. PubMed ID: 15157243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD; Castillejo MI; Grima K; Hillyer CD
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor.
    Valbonesi M; De Luigi MC; Lercari G; Florio G; Bruni R; Van Lint MT; Occhini D
    Int J Artif Organs; 2000 Sep; 23(9):642-6. PubMed ID: 11059888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A.
    Harris SB; Josephson CD; Kost CB; Hillyer CD
    Transfusion; 2007 Aug; 47(8):1412-7. PubMed ID: 17655585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravascular hemolysis secondary to ABO incompatible platelet products. An underrecognized transfusion reaction.
    McManigal S; Sims KL
    Am J Clin Pathol; 1999 Feb; 111(2):202-6. PubMed ID: 9930141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolysis after ABO-incompatible platelet transfusions.
    Chow MP; Yung CH; Hu HY; Tzeng CH
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Aug; 48(2):131-4. PubMed ID: 1654184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets.
    Cooling LL; Downs TA; Butch SH; Davenport RD
    Transfusion; 2008 Oct; 48(10):2106-13. PubMed ID: 18631162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemolytic transfusion reaction in a pediatric patient following transfusion of apheresis platelets.
    Sapatnekar S; Sharma G; Downes KA; Wiersma S; McGrath C; Yomtovían R
    J Clin Apher; 2005 Dec; 20(4):225-9. PubMed ID: 16265630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategy.
    Pagano MB; Katchatag BL; Khoobyari S; Van Gerwen M; Sen N; Rebecca Haley N; Gernsheimer TB; Hess JR; Metcalf RA
    Transfusion; 2019 Apr; 59(4):1246-1251. PubMed ID: 30592057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of ABO minor incompatible platelets transfusions using a rapid infuser.
    Jung Y; Luo O; Sen N; Li FM; Hasan RA; Hess AS; Hess JR; Sabath DE; Tsang HC; Pagano MB
    Transfusion; 2024 Mar; 64(3):449-453. PubMed ID: 38299721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of mediators of systemic inflammatory response syndrome in the course of a severe delayed hemolytic transfusion reaction caused by anti-D.
    von Zabern I; Ehlers M; Grunwald U; Mauermann K; Greinacher A
    Transfusion; 1998 May; 38(5):459-68. PubMed ID: 9633559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction.
    Sadani DT; Urbaniak SJ; Bruce M; Tighe JE
    Transfus Med; 2006 Oct; 16(5):375-9. PubMed ID: 16999762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An acute hemolytic transfusion reaction caused by an anti-P1 that reacted at 37 degrees C.
    Arndt PA; Garratty G; Marfoe RA; Zeger GD
    Transfusion; 1998 Apr; 38(4):373-7. PubMed ID: 9595020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolysis following an out-of-group platelet transfusion in an 8-month-old with Langerhans cell histiocytosis.
    Angiolillo A; Luban NL
    J Pediatr Hematol Oncol; 2004 Apr; 26(4):267-9. PubMed ID: 15087958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.